MEI PHARMA, INC.
33Patents
33Active
33Granted
54Portfolio score
Filing activity: Dec 31, 2009 → Jun 21, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8957109B2 | Chroman derivatives, medicaments and use in therapy | Human Necessities | 17 | Active |
| US9198895B2 | Chroman derivatives, medicaments and use in therapy | Human Necessities | 14 | Active |
| US9381186B2 | Substituted chroman derivatives, medicaments and use in therapy | Human Necessities | 14 | Active |
| US9138478B2 | Substituted chroman derivatives, medicaments and use in therapy | Human Necessities | 14 | Active |
| US9708283B2 | Isoflavonoid compositions and methods for the treatment of cancer | Chemistry; Metallurgy | 11 | Active |
| US8551988B2 | Benzimidazole derivatives: preparation and pharmaceutical applications | Emerging Cross-Sectional Technologies | 11 | Active |
| US9663484B2 | Isoflavonoid compounds and methods for the treatment of cancer | Chemistry; Metallurgy | 10 | Active |
| US9981936B2 | Isoflavonoid compositions and methods for the treatment of cancer | Chemistry; Metallurgy | 8 | Active |
| US10369132B2 | Isoflavonoid compositions and methods for the treatment of cancer | Chemistry; Metallurgy | 7 | Active |
| US10105346B2 | Isoflavonoid compounds and methods for the treatment of cancer | Chemistry; Metallurgy | 7 | Active |
| US10064868B2 | (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases | Chemistry; Metallurgy | 7 | Active |
| US9056852B2 | (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases | Chemistry; Metallurgy | 7 | Active |
| US10335415B2 | (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases | Chemistry; Metallurgy | 6 | Active |
| US10603324B2 | (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases | Chemistry; Metallurgy | 5 | Active |
| US10973799B2 | Isoflavonoid compositions and methods for the treatment of cancer | Chemistry; Metallurgy | 5 | Active |
| US9402829B2 | Benzimidazole derivatives: preparation and pharmaceutical applications | Emerging Cross-Sectional Technologies | 4 | Active |
| US9024029B2 | Benzimidazole derivatives: preparation and pharmaceutical applications | Emerging Cross-Sectional Technologies | 4 | Active |
| US8648092B2 | Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications | Emerging Cross-Sectional Technologies | 3 | Active |
| US11723893B2 | Isoflavonoid compositions and methods for the treatment of cancer | Chemistry; Metallurgy | 3 | Active |
| US11400097B2 | (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases | Chemistry; Metallurgy | 2 | Active |
| US9717713B2 | Benzimidazole derivatives: preparation and pharmaceutical applications | Emerging Cross-Sectional Technologies | 2 | Active |
| US11583514B2 | Isoflavonoid compounds and methods for the treatment of cancer | Chemistry; Metallurgy | 2 | Active |
| US11351176B2 | Combination therapy | Chemistry; Metallurgy | 2 | Active |
| US11304953B2 | Combination therapy | Chemistry; Metallurgy | 2 | Active |
| US10980774B2 | Combination therapies | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.